BARK vs CHWY: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
CHWY is the larger of the two ($9.25B market cap): the incumbent the market prices for continued execution (12.30x forward earnings, beta 1.45). BARK is the smaller challenger ($81.84M), priced similarly on forward earnings (-5.85x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
BARK vs CHWY: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | BARK | CHWY | What it tells you |
|---|---|---|---|
| Market cap | $81.84M | $9.25B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | -5.85 | 12.30 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 1.92 | 1.45 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 7% of range | 20% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 1.09 | 21.84 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how BARK and CHWY affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BARK and CHWY share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BARK and CHWY exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does BARK (BARK) do?
BARK, Inc. (NYSE: BARK) is a dog-focused consumer company built around its BarkBox and Super Chewer monthly subscription boxes, which pair themed toys with treats and chews. Over time it has broadened into a wider product platform: a growing consumables business (treats, chews, kibble, toppers, supplements and dental products), retail distribution through partners like Target, Walmart, Amazon, Chewy, Petco and PetSmart, and newer ventures such as BARK Air, a dog air-travel service. The company reports revenue across a direct-to-consumer (DTC) segment, which is the larger share, and a Commerce segment that sells through retail and marketplace channels. In fiscal 2026, DTC and Commerce were roughly 82% and 18% of total revenue, with Commerce growing about 50% year over year off a smaller base. BARK went public in June 2021 by merging with the Northern Star Acquisition Corp. SPAC in a deal that valued it near $1.6 billion.
What does Chewy (CHWY) do?
Chewy is the largest pure-play online retailer of pet products in the United States, selling pet food, treats, supplies, prescription medications, and other essentials, plus a growing set of pet-health services. The core of the model is Autoship, an auto-replenishment subscription that schedules recurring deliveries of food and supplies; Autoship accounts for roughly 83% of net sales, which gives Chewy unusually predictable, repeat-purchase revenue for a retailer. The company makes most of its money on product sales at retail-style gross margins, but it is steadily mixing in higher-margin revenue from Chewy Pharmacy, sponsored ads through its Chewy Ads retail-media network, and veterinary care. In fiscal 2025 (the year ended February 1, 2026) Chewy reported net sales of about $12.60 billion, up 6.2% (roughly 8.3% on a comparable 52-week basis), with around 21.3 million active customers and net sales per active customer near $600.
BARK vs CHWY: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- BARK drivers: Profitability-first turnaround; Retail Commerce expansion.
- CHWY drivers: Autoship makes the revenue sticky; Higher-margin businesses are the profit lever.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The central risk is that BARK's revenue has been declining as it cuts marketing to prioritize profits, with no guarantee it can return to growth without eroding the margins it built. For CHWY, chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot.
BARK or CHWY: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BARK if you believe its drivers more; CHWY if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BARK and CHWY guides.
BARK vs CHWY: the full fundamentals
BARK. These figures are approximate and tied to the asOf date; verify live numbers before acting. BARK is a small-cap consumer stock in transition, so its story hinges less on any single quarter's exact EPS and more on the direction of two things at once: whether revenue can stabilize and eventually grow, and whether the recently achieved positive adjusted EBITDA proves durable. Because the company deliberately shrank revenue to reach profitability, headline top-line declines can look worse than the underlying strategy, while adjusted metrics can look better than GAAP results. Always confirm current price, market cap and the latest fiscal quarter before drawing conclusions.
CHWY. Chewy is best read as a profitable but low-margin retailer that is trying to mix in higher-margin revenue, so watch the trend in gross margin and adjusted EBITDA margin more than headline sales growth. Because product sales dominate, net margins are thin (low single digits), and free cash flow is often a cleaner gauge of health than GAAP net income, which can be swung by share-based compensation and tax items. Active-customer growth and net sales per active customer show whether the base is expanding or just spending more. Since Chewy pays no dividend and reinvests in pharmacy, ads, and vet care while buying back stock, the valuation hinges on whether those higher-margin businesses scale fast enough to justify a growth multiple.
Headline figures (approximate, Jul 2026): BARK shows revenue trend Fiscal 2026 revenue was roughly $394.8 million, down about 18% year over year, reflecting deliberate marketing cuts to prioritize profitability rather than a collapse in demand, profitability Reached a second consecutive year of positive adjusted EBITDA, though the figure has been thin; GAAP results have still shown net losses, so profitability is early-stage, balance sheet Became debt-free after repaying its 2025 convertible notes in cash; management also authorized a share-repurchase program, segment mix Direct-to-consumer is the majority of revenue (roughly four-fifths); the Commerce (retail) segment is smaller but has been the faster grower; CHWY shows fy2025 net sales About $12.60 billion, up 6.2% (roughly 8.3% on a 52-week basis), fy2025 net income About $222.8 million, fy2025 adjusted ebitda About $719 million, up roughly 26%, fy2025 free cash flow Record of about $562 million.
The bottom line: BARK vs CHWY
BARK and CHWY are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BARK and CHWY exposure against your real portfolio. It is not an investment adviser.
Wondering how BARK or CHWY fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in BARK with AI
Connect the broker you already use and ask Walnut's AI how BARK fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between BARK and CHWY?
+
BARK, Inc. Chewy is the largest pure-play online retailer of pet products in the United States, selling pet food, treats, supplies, prescription medications, and other essentials, plus a growing set of pet-health services. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is BARK or CHWY the better stock?
+
Neither is universally better. CHWY is the larger incumbent; BARK is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, BARK or CHWY?
+
On forward P/E (as of August 2026), BARK trades at -5.85x and CHWY at 12.30x, so BARK is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both BARK and CHWY?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of BARK vs CHWY?
+
BARK: The central risk is that BARK's revenue has been declining as it cuts marketing to prioritize profits, with no guarantee it can return to growth without eroding the margins it built. As a small-cap consumer discretionary name, the stock can be volatile and thinly followed, and its subscription model faces churn: customers can cancel BarkBox or Super Chewer at any time, so retention and acquisition costs matter enormously. Competition is intense, from giants like Amazon and Chewy to pet-specialty retailers and established food and treat brands that dwarf BARK in scale. Consumer spending on discretionary pet products can also soften in a downturn. Profitability remains thin, with adjusted EBITDA only modestly positive, so a slip back into losses could weigh on sentiment. Adjusted EBITDA also excludes items like stock-based compensation, so headline metrics can look better than GAAP results. CHWY: Chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. Growth has slowed as the US pet market matures, with net sales up only about 6% in fiscal 2025 and active-customer growth modest after a long stretch of flat-to-declining counts following the pandemic pet boom. Competition is intense and well-capitalized: Amazon, Walmart, big-box pet chains like PetSmart and Petco, and local veterinarians all compete for the same wallet. The vet-clinic expansion carries execution and integration risk and weighs on near-term profit, while share-based compensation and ongoing BC Partners stock sales create dilution and overhang. Finally, the stock often trades at a premium that already bakes in continued margin gains, so disappointing customer growth or margin progress can pressure the shares.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell BARK or CHWY; figures are approximate and dated (as of August 2026). Verify current data before investing.